Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals

NeuroImmunoModulation

Volumn 19, Issue 4, 2012, Pages 255-265

  Van Der Zanden, Esmerij P ^a   Hilbers, Francisca W ^a   Verseijden, Caroline ^a   Van Den Wijngaard, Rene M ^a   Skynner, Mike ^b   Lee, Kevin ^b   Ulloa, Luis ^c   Boeckxstaens, Guy E ^a,d   De Jonge, Wouter J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Acetylcholine; Alpha7 nicotinic receptor; Macrophages; Monocytes; Tumor necrosis factor

Indexed keywords

BUNGAROTOXIN RECEPTOR; CHRFAM7A PROTEIN; GSK 1345038A; LIPOPOLYSACCHARIDE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BETA2; OLIVE OIL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ISOLATION; CHOLINERGIC IMMUNOMODULATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; LEUKEMIA CELL LINE; MALE; MONOCYTE; NORMAL HUMAN; PHAGOCYTOSIS; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOKING;

ADULT; CELL LINE; FEMALE; GANGLIONIC STIMULANTS; HUMANS; IMMUNOMODULATION; MALE; MONOCYTES; NICOTINE; RECEPTORS, NICOTINIC; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84858981153     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000335185     Document Type: Article

References (41)

1. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462. (Pubitemid 30367422)
2. van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, LaRosa GJ, Ulloa L, Tracey KJ, van der Poll T: The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006;130:1822-1830.
3. The FO, Boeckxstaens GE, Snoek SA, Cash JL, Bennink R, LaRosa GJ, van den Wijngaard RM, Greaves DR, de Jonge WJ: Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007;133:1219-1228. (Pubitemid 47494458)
4. Van Maanen MA, Lebre MC, van der Poll T, LaRosa GJ, Elbaum D, Vervoordeldonk MJ, Tak PP: Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009;60:114-122.
5. Yu H, Yang YH, Rajaiah R, Moudgil KD: Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anticyclic citrullinated peptide antibodies. Arthritis Rheum 2011;63:981-991.
6. Kawashima K, Yoshikawa K, Fujii YX, Moriwaki Y, Misawa H: Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 2007;80:2314-2319. (Pubitemid 46818285)
7. Sato KZ, Fujii T, Watanabe Y, Yamada S, Ando T, Kazuko F, Kawashima K: Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 1999;266:17-20. (Pubitemid 29219745)
8. van der Zanden EP, Snoek SA, Heinsbroek SE, Stanisor OI, Verseijden C, Boeckxstaens GE, Peppelenbosch MP, Greaves DR, Gordon S, de Jonge WJ: Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha-4beta2. Gastroenterology 2009;137:1029-1039.
9. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ: Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011;334:98-101.
10. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388. (Pubitemid 36157937)
11. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, Moore T, Jacobs S, Meriwether J, Choi MJ, Kim EJ, Walton K, Buiting K, Davis A, Breese C, Freedman R, Leonard S: Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998;52:173-185. (Pubitemid 28465664)
12. Benfante R, Antonini RA, De Pizzol M, Gotti C, Clementi F, Locati M, Fornasari D: Expression of the alpha7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS. J Neuroimmunol 2011;230:74-84.
13. Villiger Y, Szanto I, Jaconi S, Blanchet C, Buisson B, Krause KH, Bertrand D, Romand JA: Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes. J Neuroimmunol 2002;126:86-98. (Pubitemid 34521734)
14. de Lucas-Cerrillo AM, Maldifassi MC, Arnalich F, Renart J, Atienza G, Serantes R, Cruces J, Sanchez-Pacheco A, Andres-Mateos E, Montiel C: Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response. J Biol Chem 2011;286:594-606.
15. Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, Croghan IT, Dale LC, Schroeder DR, Hurt RD: Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126:364-371. (Pubitemid 27102520)
16. Birrenbach T, Bocker U: Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004;10:848-859. (Pubitemid 39549299)
17. Ingram JR, Rhodes J, Collins PW, Williams GT, Newcombe RG, Thomas GA: Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial. Dig Liver Dis 2005;37:832-837. (Pubitemid 44356114)
18. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, Newcombe RG, Russell MA, Feyerabend C, Thomas GA, et al: Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-815. (Pubitemid 24083559)
19. Thomas GA, Rhodes J, Green JT, Richardson C: Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 2000;76:273-279. (Pubitemid 30223939)
20. Sun M, Lee CJ, Shin HS: Reduced nicotinic receptor function in sympathetic ganglia is responsible for the hypothermia in the acetylcholinesterase knockout mouse. J Physiol 2007;578:751-764. (Pubitemid 46165507)
21. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM: The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006;131:1122-1130. (Pubitemid 44498700)
22. Snoek SA, Verstege MI, van der Zanden EP, Deeks N, Bulmer DC, Skynner M, Lee K, Te Velde AA, Boeckxstaens GE, de Jonge WJ: Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol 2010;160:322-333.
23. McGrath J, McDonald JW, Macdonald JK: Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004;CD004722.
24. De Rosa MJ, Esandi MC, Garelli A, Rayes D, Bouzat C: Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. J Neuroimmunol 2005;160:154-161. (Pubitemid 40248604)
25. Wongsriraksa A, Parsons ME, Whelan CJ: Characterisation of nicotine receptors on human peripheral blood mononuclear cells (PBMC). Inflamm Res 2009;58:38-44.
26. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ: Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 1999;289:1545-1552. (Pubitemid 29246689)
27. Smeets AJ, Westerterp-Plantenga MS: Satiety and substrate mobilization after oral fat stimulation. Br J Nutr 2006;95:795-801.
28. Lubbers T, Luyer MD, De Haan JJ, Hadfoune M, Buurman WA, Greve JW: Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of cholecystokinin-receptors. Ann Surg 2009;249:481-487.
29. de Jonge WJ, Ulloa L: The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007;151:915-929.
30. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005;202:1023-1029. (Pubitemid 41464495)
31. Sykes AP, Brampton C, Klee S, Chander CL, Whelan C, Parsons ME: An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res 2000;49:311-319.
32. Severance EG, Dickerson FB, Stallings CR, Origoni AE, Sullens A, Monson ET, Yolken RH: Differentiating nicotine- versus schizophrenia-associated decreases of the alpha7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes. J Neural Transm 2009;116:213-220.
33. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L: Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006;203:1623-1628.
34. Vida G, Pena G, Deitch EA, Ulloa L: Alpha7-cholinergic receptor mediates vagal induction of splenic norepinephrine. J Immunol 2011;186:4340-4346.
35. Damsgaard CT, Lauritzen L, Calder PC, Kjaer TM, Frokiaer H: Whole-blood culture is a valid low-cost method to measure monocytic cytokines - a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J Immunol Methods 2009;340:95-101.
36. Hamano R, Takahashi HK, Iwagaki H, Kanke T, Liu K, Yoshino T, Sendo T, Nishibori M, Tanaka N: Stimulation of adenosine A2A receptor inhibits LPS-induced expression of intercellular adhesion molecule 1 and production of TNF-alpha in human peripheral blood mononuclear cells. Shock 2008;29:154-159.
37. Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, Pickkers P: GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol 2009;78:863-872.
38. Leite MS, Pacheco P, Gomes RN, Guedes AT, Castro-Faria-Neto HC, Bozza PT, Koatz VL: Mechanisms of increased survival after lipopolysaccharide- induced endotoxic shock in mice consuming olive oil-enriched diet. Shock 2005;23:173-178. (Pubitemid 40222955)
39. Sanchez-Fidalgo S, Villegas I, Cardeno A, Talero E, Sanchez-Hidalgo M, Motilva V, Alarcon de la Lastra C: Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clin Nutr 2010;29:663-673.
40. Simonian HP, Kresge KM, Boden GH, Parkman HP: Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 2005;17:348-354. (Pubitemid 40768907)
41. Schwartz TW: Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983;85:1411-1425.